标记临床研究(XOMA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XOMA 标记临床研究

未开盘 07-22 16:00:00 EDT

25.45

-0.03

-0.12%

盘后25.45

+0.000.00%

16:08 EDT

最高25.90	最低25.42	成交量1.82万
今开25.59	昨收25.48	日振幅1.88%
总市值3.05亿	流通市值2.35亿	总股本1,197万
成交额46.42万	换手率0.20%	流通股本923.61万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"XOMA","market":"US","secType":"STK","nameCN":"标记临床研究","latestPrice":25.45,"timestamp":1753214400000,"preClose":25.48,"halted":0,"volume":18158,"hourTrading":{"tag":"盘后","latestPrice":25.45,"preClose":25.45,"latestTime":"16:08 EDT","volume":888,"amount":22599.6,"timestamp":1753214884513},"delay":0,"floatShares":9236088,"shares":11966889,"eps":-0.73104,"marketStatus":"未开盘","change":-0.03,"latestTime":"07-22 16:00:00 EDT","open":25.59,"high":25.9,"low":25.42,"amount":464244.641784,"amplitude":0.018838,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.73104,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753257600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":517896000000,"exchange":"NASDAQ","adjPreClose":25.48,"postHourTrading":{"tag":"盘后","latestPrice":25.45,"preClose":25.45,"latestTime":"16:08 EDT","volume":888,"amount":22599.6,"timestamp":1753214884513},"volumeRatio":0.524598,"impliedVol":0.2863,"impliedVolPercentile":0.2169},"requestUrl":"/m/hq/s/XOMA","defaultTab":"news","newsList":[{"id":"2551196285","title":"标记临床研究盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551196285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551196285?lang=zh_cn&edition=full","pubTime":"2025-07-16 00:15","pubTimestamp":1752596153,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日00时15分，标记临床研究股票出现异动，股价大幅下跌5.08%。截至发稿，该股报26.35美元/股，成交量1.0041万股，换手率0.08%，振幅5.69%。标记临床研究股票所在的生物技术行业中，整体跌幅为1.00%。标记临床研究公司简介：XOMA Royalty Corp是一家生物技术专利使用费聚合公司，在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716001553a44ccabc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716001553a44ccabc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"gpt_icon":0},{"id":"2550650353","title":"标记临床研究盘中异动 股价大涨5.29%报27.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550650353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550650353?lang=zh_cn&edition=full","pubTime":"2025-07-10 02:14","pubTimestamp":1752084867,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日02时14分，标记临床研究股票出现异动，股价快速拉升5.29%。截至发稿，该股报27.86美元/股，成交量3.788万股，换手率0.32%，振幅2.25%。最近的财报数据显示，该股实现营业收入15.91百万美元，净利润2.37百万美元，每股收益0.06美元，毛利15.37百万美元，市盈率-37.17倍。标记临床研究股票所在的生物技术行业中，整体涨幅为1.29%。XOMA获得未来的经济权利，卖方获得非稀释性、无追索权的资金，可用于推进其内部候选药物或用于一般公司目的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710021427a440d1c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710021427a440d1c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"gpt_icon":0},{"id":"2548841218","title":"标记临床研究盘中异动 快速上涨5.56%报26.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548841218","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548841218?lang=zh_cn&edition=full","pubTime":"2025-07-02 02:56","pubTimestamp":1751396178,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日02时56分，标记临床研究股票出现波动，股价快速拉升5.56%。截至发稿，该股报26.60美元/股，成交量6.0056万股，换手率0.50%，振幅6.77%。标记临床研究股票所在的生物技术行业中，整体涨幅为0.73%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。XOMA获得未来的经济权利，卖方获得非稀释性、无追索权的资金，可用于推进其内部候选药物或用于一般公司目的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702025618a4c978a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702025618a4c978a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"gpt_icon":0},{"id":"2548112460","title":"标记临床研究盘中异动 股价大跌6.00%报25.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548112460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548112460?lang=zh_cn&edition=full","pubTime":"2025-07-01 00:51","pubTimestamp":1751302276,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日00时51分，标记临床研究股票出现异动，股价快速下挫6.00%。截至发稿，该股报25.84美元/股，成交量6.935万股，换手率0.58%，振幅5.40%。标记临床研究股票所在的生物技术行业中，整体跌幅为0.15%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。XOMA获得未来的经济权利，卖方获得非稀释性、无追索权的资金，可用于推进其内部候选药物或用于一般公司目的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701005116a4c70de0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701005116a4c70de0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"gpt_icon":0},{"id":"2545044144","title":"标记临床研究盘中异动 下午盘大幅拉升5.45%报25.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545044144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545044144?lang=zh_cn&edition=full","pubTime":"2025-06-24 01:45","pubTimestamp":1750700739,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日01时45分，标记临床研究股票出现异动，股价大幅拉升5.45%。截至发稿，该股报25.36美元/股，成交量6.9315万股，换手率0.58%，振幅6.38%。机构评级方面，在所有4家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。标记临床研究股票所在的生物技术行业中，整体涨幅为0.40%。XOMA获得未来的经济权利，卖方获得非稀释性、无追索权的资金，可用于推进其内部候选药物或用于一般公司目的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624014540a7197966&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624014540a7197966&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"gpt_icon":0},{"id":"2541867898","title":"标记临床研究盘中异动 下午盘快速上涨5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541867898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541867898?lang=zh_cn&edition=full","pubTime":"2025-06-07 01:59","pubTimestamp":1749232752,"startTime":"0","endTime":"0","summary":"北京时间2025年06月07日01时59分，标记临床研究股票出现异动，股价快速拉升5.86%。截至发稿，该股报26.47美元/股，成交量1.0183万股，换手率0.09%，振幅3.84%。标记临床研究股票所在的生物技术行业中，整体涨幅为0.44%。标记临床研究公司简介：XOMA Royalty Corp是一家生物技术专利使用费聚合公司，在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607015912a6fd7d6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250607015912a6fd7d6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"gpt_icon":0},{"id":"2539266294","title":"标记临床研究盘中异动 股价大涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539266294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539266294?lang=zh_cn&edition=full","pubTime":"2025-05-29 22:08","pubTimestamp":1748527706,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日22时08分，标记临床研究股票出现异动，股价急速拉升6.08%。截至发稿，该股报26.68美元/股，成交量3819股，换手率0.03%，振幅1.77%。标记临床研究股票所在的生物技术行业中，整体涨幅为0.63%。标记临床研究公司简介：XOMA Royalty Corp是一家生物技术专利使用费聚合公司，在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505292208269769ea09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505292208269769ea09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"gpt_icon":0},{"id":"2537956356","title":"标记临床研究盘中异动 下午盘股价大跌5.08%报25.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537956356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537956356?lang=zh_cn&edition=full","pubTime":"2025-05-22 03:09","pubTimestamp":1747854572,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日03时09分，标记临床研究股票出现波动，股价快速下跌5.08%。截至发稿，该股报25.25美元/股，成交量3.4489万股，换手率0.29%，振幅6.92%。机构评级方面，在所有4家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。标记临床研究股票所在的生物技术行业中，整体跌幅为1.16%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522030932a6e7cce0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522030932a6e7cce0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"gpt_icon":0},{"id":"2536484016","title":"标记临床研究盘中异动 股价大跌6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536484016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536484016?lang=zh_cn&edition=full","pubTime":"2025-05-20 21:31","pubTimestamp":1747747877,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日21时31分，标记临床研究股票出现异动，股价大幅跳水6.00%。截至发稿，该股报25.83美元/股，成交量3542股，换手率0.03%，振幅0.00%。标记临床研究股票所在的生物技术行业中，整体涨幅为0.07%。标记临床研究公司简介：XOMA Royalty Corp是一家生物技术专利使用费聚合公司，在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520213117a6e62281&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520213117a6e62281&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"gpt_icon":0},{"id":"2536259438","title":"标记临床研究2025财年第一财季实现净利润2.37百万美元，同比增加127.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536259438","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536259438?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:01","pubTimestamp":1747584095,"startTime":"0","endTime":"0","summary":"5月19日，标记临床研究公布财报，公告显示公司2025财年第一财季净利润为2.37百万美元，同比增加127.56%；其中营业收入为15.91百万美元，同比增加967.79%，每股基本收益为0.06美元。从资产负债表来看，标记临床研究总负债1.28亿美元，其中短期债务14.16百万美元，资产负债比为1.67，流动比率为0.06。机构评级：截至2025年5月19日，当前有3家机构对标记临床研究目标价做出预测，其中目标均价为64.67美元，其中最低目标价为35.00美元，最高目标价为104.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000549a482f16a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000549a482f16a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA"],"gpt_icon":0},{"id":"2535078045","title":"标记临床研究盘中异动 快速下挫8.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535078045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535078045?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:35","pubTimestamp":1747229705,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时35分，标记临床研究股票出现波动，股价大幅下挫8.84%。截至发稿，该股报25.06美元/股，成交量965股，换手率0.01%，振幅7.58%。标记临床研究股票所在的生物技术行业中，整体涨幅为0.25%。标记临床研究公司简介：XOMA Royalty Corp是一家生物技术专利使用费聚合公司，在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213505a6df0988&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213505a6df0988&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"gpt_icon":0},{"id":"2533395206","title":"标记临床研究盘中异动 急速拉升5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533395206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533395206?lang=zh_cn&edition=full","pubTime":"2025-05-08 02:00","pubTimestamp":1746640843,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日02时00分，标记临床研究股票出现波动，股价大幅拉升5.46%。截至发稿，该股报24.30美元/股，成交量1.8754万股，换手率0.16%，振幅6.03%。标记临床研究股票所在的生物技术行业中，整体跌幅为0.85%。标记临床研究公司简介：XOMA Royalty Corp是一家生物技术专利使用费聚合公司，在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050802004394ef8037&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050802004394ef8037&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"gpt_icon":0},{"id":"2532400597","title":"标记临床研究盘中异动 早盘股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532400597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532400597?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:57","pubTimestamp":1746107841,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时57分，标记临床研究股票出现波动，股价急速下跌5.18%。截至发稿，该股报22.80美元/股，成交量1210股，换手率0.01%，振幅0.00%。标记临床研究股票所在的生物技术行业中，整体跌幅为1.26%。标记临床研究公司简介：XOMA Royalty Corp是一家生物技术专利使用费聚合公司，在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501215721a6d01622&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501215721a6d01622&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"gpt_icon":0},{"id":"2529555827","title":"标记临床研究盘中异动 下午盘急速拉升5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529555827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529555827?lang=zh_cn&edition=full","pubTime":"2025-04-23 02:39","pubTimestamp":1745347149,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日02时39分，标记临床研究股票出现异动，股价快速拉升5.27%。截至发稿，该股报23.26美元/股，成交量1.0051万股，换手率0.08%，振幅5.21%。标记临床研究股票所在的生物技术行业中，整体涨幅为1.96%。标记临床研究公司简介：XOMA Royalty Corp是一家生物技术专利使用费聚合公司，在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230239109740fd26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230239109740fd26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"gpt_icon":0},{"id":"2529238040","title":"标记临床研究盘中异动 急速拉升5.24%报22.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529238040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529238040?lang=zh_cn&edition=full","pubTime":"2025-04-22 00:38","pubTimestamp":1745253481,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日00时38分，标记临床研究股票出现异动，股价急速上涨5.24%。截至发稿，该股报22.29美元/股，成交量5674股，换手率0.05%，振幅4.98%。机构评级方面，在所有4家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。标记临床研究股票所在的生物技术行业中，整体跌幅为0.07%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422003802a6c2a2dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422003802a6c2a2dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"gpt_icon":0},{"id":"2527448413","title":"标记临床研究盘中异动 快速拉升6.09%报21.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527448413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527448413?lang=zh_cn&edition=full","pubTime":"2025-04-15 22:09","pubTimestamp":1744726164,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日22时09分，标记临床研究股票出现波动，股价急速拉升6.09%。截至发稿，该股报21.52美元/股，成交量749股，换手率0.01%，振幅1.87%。标记临床研究股票所在的生物技术行业中，整体涨幅为0.36%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。当XOMA获得未来的经济权利时，卖方将获得非稀释性、无追索权的资金，这些资金可用于推进其内部候选药物或用于一般公司用途。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415220924a6bb5541&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415220924a6bb5541&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"gpt_icon":0},{"id":"2518984274","title":"标记临床研究盘中异动 早盘股价大跌7.38%报20.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518984274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518984274?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:26","pubTimestamp":1741616797,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时26分，标记临床研究股票出现异动，股价大幅跳水7.38%。截至发稿，该股报20.21美元/股，成交量1.4508万股，换手率0.12%，振幅8.57%。最近的财报数据显示，该股实现营业收入7.20百万美元，净利润-17.24百万美元，每股收益-1.59美元，毛利7.19百万美元，市盈率-6.83倍。标记临床研究股票所在的生物技术行业中，整体涨幅为0.39%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222637abf31101&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222637abf31101&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XOMA"],"gpt_icon":0},{"id":"2516512316","title":"标记临床研究盘中异动 快速下挫5.73%报21.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516512316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516512316?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:05","pubTimestamp":1741025132,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时05分，标记临床研究股票出现波动，股价大幅下跌5.73%。截至发稿，该股报21.40美元/股，成交量2.8404万股，换手率0.24%，振幅4.98%。标记临床研究股票所在的生物技术行业中，整体涨幅为0.30%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。当XOMA获得未来的经济权利时，卖方将获得非稀释性、无追索权的资金，这些资金可用于推进其内部候选药物或用于一般公司用途。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040205339637de0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040205339637de0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"gpt_icon":0},{"id":"2512162677","title":"标记临床研究盘中异动 大幅下跌5.08%报25.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512162677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512162677?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:11","pubTimestamp":1739895091,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时11分，标记临床研究股票出现波动，股价大幅下跌5.08%。截至发稿，该股报25.40美元/股，成交量6904股，换手率0.06%，振幅2.77%。标记临床研究股票所在的生物技术行业中，整体涨幅为0.92%。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。当XOMA获得未来的经济权利时，卖方将获得非稀释性、无追索权的资金，这些资金可用于推进其内部候选药物或用于一般公司用途。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219001131988a0f02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219001131988a0f02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"gpt_icon":0},{"id":"2508125463","title":"标记临床研究盘中异动 大幅跳水5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508125463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508125463?lang=zh_cn&edition=full","pubTime":"2025-02-04 01:09","pubTimestamp":1738602541,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日01时09分，标记临床研究股票出现异动，股价急速下跌5.67%。截至发稿，该股报25.10美元/股，成交量1.4863万股，换手率0.13%，振幅3.14%。标记临床研究股票所在的生物技术行业中，整体跌幅为0.68%。标记临床研究公司简介：XOMA Royalty Corp是一家生物技术专利使用费聚合公司，在帮助生物技术公司实现改善人类健康的目标方面发挥着重要作用。XOMA获得了与已授权给制药或生物技术公司的商业化前候选治疗相关的潜在未来经济效益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204010901abc127a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204010901abc127a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XOMA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xoma.com","stockEarnings":[{"period":"1week","weight":-0.0308},{"period":"1month","weight":0.0582},{"period":"3month","weight":0.0904},{"period":"6month","weight":-0.0215},{"period":"1year","weight":-0.1098},{"period":"ytd","weight":-0.0316}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0582},{"period":"3month","weight":0.1745},{"period":"6month","weight":0.0313},{"period":"1year","weight":0.1338},{"period":"ytd","weight":0.073}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"XOMA Royalty Corporation内华达州的一家公司。该公司是一家生物技术版税聚合商，在帮助生物技术公司实现改善人类健康的目标方面发挥着独特的作用。该公司获得了与已授权给制药或生物技术公司的预商业化和商业化治疗候选药物相关的潜在未来经济性。","yearOnYearQuotes":[{"month":1,"riseRate":0.589744,"avgChangeRate":0.056267},{"month":2,"riseRate":0.487179,"avgChangeRate":-0.011749},{"month":3,"riseRate":0.384615,"avgChangeRate":-0.000111},{"month":4,"riseRate":0.487179,"avgChangeRate":-0.011164},{"month":5,"riseRate":0.538462,"avgChangeRate":0.057471},{"month":6,"riseRate":0.435897,"avgChangeRate":0.003996},{"month":7,"riseRate":0.475,"avgChangeRate":-0.005183},{"month":8,"riseRate":0.461538,"avgChangeRate":0.045754},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.015868},{"month":10,"riseRate":0.410256,"avgChangeRate":-0.030781},{"month":11,"riseRate":0.538462,"avgChangeRate":0.023989},{"month":12,"riseRate":0.461538,"avgChangeRate":0.048522}],"exchange":"NASDAQ","name":"标记临床研究","nameEN":"XOMA Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"标记临床研究(XOMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供标记临床研究(XOMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"标记临床研究,XOMA,标记临床研究股票,标记临床研究股票老虎,标记临床研究股票老虎国际,标记临床研究行情,标记临床研究股票行情,标记临床研究股价,标记临床研究股市,标记临床研究股票价格,标记临床研究股票交易,标记临床研究股票购买,标记临床研究股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"标记临床研究(XOMA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供标记临床研究(XOMA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}